NCT01204125 - Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients | Biotech Hunter

Enrollment

141

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

February 28, 2017

Conditions

Breast Cancer Female

Interventions

DRUG

paclitaxel

"Pharmaceutical form:solution for infusion~Route of administration: intravenous"

DRUG

Iniparib (SAR2405550 -BSI-201)

"Pharmaceutical form : solution for infusion~Route of administration :Intravenous"

Trial Locations (25)

10003

Investigational Site Number 724009, Cáceres

14004

Investigational Site Number 724013, Córdoba

15706

Investigational Site Number 724018, Santiago de Compostela

20357

Investigational Site Number 276004, Hamburg

23007

Investigational Site Number 724012, Jaén

25030

Investigational Site Number 250001, Besançon

25198

Investigational Site Number 724002, Lleida

28033

Investigational Site Number 724005, Madrid

28041

Investigational Site Number 724016, Madrid

31052

Investigational Site Number 250002, Toulouse

33076

Investigational Site Number 250004, Bordeaux

41009

Investigational Site Number 724017, Seville

41013

Investigational Site Number 724010, Seville

41061

Investigational Site Number 276001, Mönchengladbach

43201

Investigational Site Number 724007, Reus

46009

Investigational Site Number 724011, Valencia

46010

Investigational Site Number 724015, Valencia

50931

Investigational Site Number 276002, Cologne

69677

Investigational Site Number 250006, Bron

75475

Investigational Site Number 250003, Paris

91054

Investigational Site Number 276003, Erlangen

94805

Investigational Site Number 250005, Villejuif

08035

Investigational Site Number 724001, Barcelona

07014

Investigational Site Number 724006, Islas Baleares

03186

Investigational Site Number 724003, Torrevieja